OC
ELV icon

Optima Capital’s Elevance Health ELV Stock Holding History

Optima Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-60
Closed -$21K – 504
2025
Q4 		$21K Buy
+60
New +$20.3K 0.01% 419

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Optima Capital's ELV Position: Q1 2026 in Review

Optima Capital sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 60 shares — an estimated $21K sold.

Optima Capital first reported a position in ELV in Q4 2025 and held it in 1 quarter. The position peaked at $21K in Q4 2025. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Optima Capital reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Optima Capital sold 60 Elevance Health shares in Q1 2026, an estimated $21K.
  • Optima Capital first reported a position in Elevance Health in Q4 2025 and held it in 1 quarter.
  • Optima Capital's Elevance Health position peaked at $21K in Q4 2025.
  • 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Optima Capital's 13F filing for Q1 2026, filed 5 May 2026.